Active P200
Baptist Health / Miami Cancer Institute
Active
A South Florida USTMA referral site supporting complex benign hematology, TMA care, thrombosis expertise, and clinical research.
View site →USTMA national network
Find a TMA Center
Search USTMA's clinical and research network by institution or location. Active and prospective sites are clearly identified.
Current network
Active sites
Active P200
Baylor College of Medicine
Active
A Houston-based USTMA site with focused expertise in TTP, thrombotic microangiopathy, benign hematology, and clinical research.
View site →Active P200
Brigham and Women’s Hospital
Active
A major academic hematology site with expertise in hemostasis, thrombosis, platelet disorders, and complex TMA evaluation.
View site →Active P200
Cleveland Clinic
Active
A major referral site with expertise in TTP, complement-mediated TMA, immune hematology, thrombosis, and platelet disorders.
View site →Active P200
Duke University
Active
A USTMA site specializing in benign hematology, TMA, immune cytopenias, hemostasis, and clinical-trial access for rare blood disorders.
View site →Active P200
East Carolina University / ECU Health
Active
An academic hematology site extending access to TMA expertise and research for patients across eastern North Carolina.
View site →Active P200
Emory University / Children’s Healthcare of Atlanta
Active
A USTMA site bringing together adult and pediatric TMA expertise, complement biology, translational research, and clinical care.
View site →Active P200
Johns Hopkins University
Active
A major USTMA clinical and research site focused on iTTP, complement-mediated TMA, survivorship, neurologic outcomes, and long-term patient needs.
View site →Active P200
Mayo Clinic
Active
A multidisciplinary USTMA site with specialized expertise in TMA, complement disorders, coagulation medicine, and complex diagnostic evaluation.
View site →Active P200
Ohio State University
Active
A foundational USTMA research site with deep expertise in TTP, complement-mediated TMA, specialized laboratory testing, and biospecimen-based research.
View site →Active P200
Tulane University
Active
A USTMA site contributing patient-centered, outcomes, access, and health-disparities research within a rare blood-disorders program.
View site →Active P200
University of Alabama at Birmingham
Active
A USTMA site combining expertise in thrombotic microangiopathy, hemostasis, thrombosis, benign hematology, and outcomes research.
View site →Active P200
University of Kansas Medical Center
Active
A USTMA research site with deep expertise in immune TTP, ADAMTS13 biology, pathogenic antibodies, biomarkers, and translational science.
View site →Active P200
University of Minnesota
Active
A central USTMA research site focused on iTTP, rare blood disorders, long-term outcomes, clinical trials, and biospecimen research.
View site →Active P200
University of North Carolina at Chapel Hill
Active
A USTMA site combining benign hematology, coagulation, transfusion medicine, therapeutic apheresis, and TTP expertise.
View site →Active P200
University of Oklahoma Health Sciences Center
Active
A longstanding TTP research center with distinctive expertise in epidemiology, survivorship, health disparities, and longitudinal outcomes.
View site →Active P200
University of Pennsylvania
Active
A Penn Blood Disorders Center site with extensive expertise in iTTP, complement-mediated TMA, thrombosis, and neurologic outcomes.
View site →Active P200
University of Rochester Medical Center
Active
A benign hematology site with expertise in TTP, HUS/TMA, thrombocytopenia, coagulation disorders, and longitudinal patient care.
View site →Active P200
University of Utah
Active
A multidisciplinary benign hematology and hemostasis/thrombosis site with focused expertise in TTP/TMA and rare blood disorders.
View site →Growing the network
Prospective sites
Prospective
Children’s Hospital Colorado
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
Stanford University
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
University of California, Irvine
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
University of California, San Francisco
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
University of Washington / Fred Hutch
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
UT Southwestern Medical Center
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
Wake Forest
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
Washington University in St. Louis
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
Weill Cornell Medicine
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →Prospective
Yale University
Prospective
Prospective USTMA network site. Participation details are being developed and should be confirmed before public clinical or research claims are added.
View site →